aortic stenosis

37 Congreso Uruguayo de Cardiología

37th Annual Meeting of the Uruguayan Society of Cardiology: Registration Waiver for SOLACI Members!

The 37° Annual Meeting of the Uruguayan Society of Cardiology, to be held virtually from May 26 thru 28 by the Uruguayan Society of Cardiology (SUC), is of the highest academic and scientific value.&nbsp; The event will have relevant international guests and will run through different topics, such as atrial fibrillation, chronic coronary syndromes, type<a href="https://solaci.org/en/2021/05/21/37th-annual-meeting-of-the-uruguayan-society-of-cardiology-registration-waiver-for-solaci-members/" title="Read more" >...</a>

ACC 2021 | ATLANTIS: Apixaban post TAVI vs tratamiento estándar

ACC 2021 | ATLANTIS: Apixaban After TAVR vs. Standard of Care

Adding apixaban to the treatment of patients undergoing transcatheter aortic valve replacement (TAVR) was non-superior to standard antithrombotic treatment, according to the randomized ATLANTIS trial presented today at the American College of Cardiology (ACC) 2021 Congress. Given its easy indication and good safety profile, it could be an option to vitamin&nbsp;K antagonists for patients with<a href="https://solaci.org/en/2021/05/18/acc-2021-atlantis-apixaban-after-tavr-vs-standard-of-care/" title="Read more" >...</a>

Sedación consciente vs anestesia general en el TAVI

SOLVE-TAVI after 12-month followup: self-expanding vs. balloon expandable and general vs. local anesthesia

The ambitious SOLVE-TAVI (soon to be published in JACC) is aimed at answering to of the most important questions we make when facing a TAVR procedure: What valve do we choose, a self-expanding or a balloon expandable? And once we have chosen our device, do we proceed with general anesthesia or conscious sedation?&nbsp; &nbsp; The<a href="https://solaci.org/en/2021/05/04/solve-tavi-after-12-month-followup-self-expanding-vs-balloon-expandable-and-general-vs-local-anesthesia/" title="Read more" >...</a>

The Most Read Articles on Interventional Cardiology of March

The Most Read Articles in Interventional Cardiology of March

01- Surgeons’ Claim on Low-Risk Patients with Aortic Stenosis Recent randomized trials including low-risk patients showed positive results for transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement. Read more HERE 02- Major Cause of Myocardial Injury by COVID-19 The most common cause of myocardial necrosis in patient undergoing COVID-19 infection is microthrombi.&nbsp;These<a href="https://solaci.org/en/2021/04/07/the-most-read-articles-in-interventional-cardiology-of-march/" title="Read more" >...</a>

Incidencia, características y tratamiento de la trombosis valvular post TAVI

Data that Can Change TAVR and SAVR Strategy

In many relatively young patients with severe aortic stenosis, we rule out the idea of a mechanical valve, opting for a surgical aortic valve replacement (SAVR) with a bioprosthesis; we bet once the surgical bioprosthesis deteriorates, we will be able to solve it with transcatheter aortic valve replacement (TAVR) of the failed surgical valve: TAV-in-SAV.&nbsp;<a href="https://solaci.org/en/2021/03/04/data-that-can-change-tavr-and-savr-strategy/" title="Read more" >...</a>

tavi estenosis aortica severa

Diastolic Dysfunction and TAVR: Prognosis before and after Procedure

The PARTNER 2 SAPIEN 3 showed baseline diastolic dysfunction is a predictor of clinical events after 2 years of TAVR. As expected, improved diastolic function after procedure immediately changes prognosis.&nbsp; Though these outcomes did meet our expectations, very few studies have shown hard evidence linking diastolic dysfunction and aortic stenosis.&nbsp; All patients included in the<a href="https://solaci.org/en/2021/03/02/diastolic-dysfunction-and-tavr-prognosis-before-and-after-procedure/" title="Read more" >...</a>

The Ten Commandments in Adult Congenital Heart Disease

Adult congenital heart disease is a life-long condition that requires appropriate follow-up by experts. Said follow-up is paramount to diagnosing specific and highly variable complications in a timely manner. The recently published European Society of Cardiology guidelines for the management of congenital heart disease calls for a summary of its most important aspects as “ten<a href="https://solaci.org/en/2020/12/15/the-ten-commandments-in-adult-congenital-heart-disease/" title="Read more" >...</a>

Most read articles of november

The Most Read Articles in Interventional Cardiology

01- Ticagrelor or Prasugrel in ST Elevation MI In patients undergoing ST elevation acute myocardial infarction (STEMI) receiving primary PCI, no significative differences between prasugrel and ticagrelor were found. However, the latter was associated to a significantly higher number of repeat MI when considered separately.&nbsp; Read more HERE 02- Number of Hours of Sleep and<a href="https://solaci.org/en/2020/12/02/the-most-read-articles-in-interventional-cardiology/" title="Read more" >...</a>

Historia natural de la infección asintomática por COVID-19

Natural History of Asymptomatic COVID-19 Infection

Information on the natural history of asymptomatic infection with the new coronavirus (COVID-19) remains scarce. We are just beginning to understand what happens with patients with severe disease. The outbreak of COVID-19 on the cruise ship Diamond Princess provided a unique opportunity to study contacts and patients with asymptomatic infection within a closed population. This<a href="https://solaci.org/en/2020/11/03/natural-history-of-asymptomatic-covid-19-infection/" title="Read more" >...</a>

Efficacy of Remdesivir against COVID-19

This final report published in NEJM about the efficacy of remdesivir against COVID-19 infection vs placebo showed its superiority though only in soft end points, which does not seem to modify the course of this pandemic. Multiple drugs initially promising have been shown ineffective against the new virus. The case of hydroxychloroquine resulted paradigmatic: not<a href="https://solaci.org/en/2020/11/02/efficacy-of-remdesivir-against-covid-19/" title="Read more" >...</a>

Top